JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Findlay, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Findlay, I.

Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide

I Findlay

Laboratoire de Physiologie Comparee (URA CNRS 1121), Batiment 443, Universite de Paris, France.

The effects of the sulphonylurea drug glibenclamide were tested upon ATP-sensitive K+ (KATP) channels activated by 20 microM SR 44866 in isolated ventricular myocytes from guinea pig hearts. Glibenclamide inhibited the openings of KATP channels in both cell-attached and excised inside-out membrane patches. Glibenclamide inhibited the whole- cell KATP current (I-KATP) with an EC50 of 6 nM and Hill Coefficient of 1.26. The kinetics of the onset of inhibition of I-KATP were complex and dose-dependent. The recovery of I-KATP from inhibition was largely dose-independent. The application of glibenclamide for short periods of time was followed by the continued development of inhibition. These results suggest that the cell was loaded with the drug before it interacted with the KATP channel. It is proposed that the sulphonylurea receptor site is to be found in the lipid phase of the membrane. In consequence critical factors involved in the sulphonylurea drug-induced inhibition of KATP channels will include the rates of drug absorption into and exit from the membrane lipid. That sulphonylureas will be concentrated in the membrane lipid suggests that the EC50 value for channel inhibition does not represent the true affinity of the drugs for their receptor.

Volume 261, Issue 2, pp. 540-545, 05/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. V. Cuong, N. Kim, J. B. Youm, H. Joo, M. Warda, J.-W. Lee, W. S. Park, T. Kim, S. Kang, H. Kim, et al.
Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1808 - H1817.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. M. Doliba, M. Z. Vatamaniuk, C. W. Buettger, W. Qin, H. W. Collins, S. L. Wehrli, R. D. Carr, and F. M. Matschinsky
Differential Effects of Glucose and Glyburide on Energetics and Na+ Levels of {beta}HC9 Cells: Nuclear Magnetic Resonance Spectroscopy and Respirometry Studies
Diabetes, February 1, 2003; 52(2): 394 - 402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-H. Jiao, P. Baumann, A. Baron, A. Roatti, R. A. Pence, and A. J. Baertschi
Sulfonylurea receptor ligands modulate stretch-induced ANF secretion in rat atrial myocyte culture
Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H2028 - H2038.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Hu, S. Wang, and B. E. Dunning
Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and beta -Cell KATP Channels
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1372 - 1379.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
A. Baron, L. van Bever, D. Monnier, A. Roatti, and A. J. Baertschi
A Novel KATP Current in Cultured Neonatal Rat Atrial Appendage Cardiomyocytes
Circ. Res., October 15, 1999; 85(8): 707 - 715.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Link, P. J. Wang, B. A. VanderBrink, E. Avelar, N. G. Pandian, B. J. Maron, and N. A. M. Estes III
Selective Activation of the K+ATP Channel Is a Mechanism by Which Sudden Death Is Produced by Low-Energy Chest-Wall Impact (Commotio Cordis)
Circulation, July 27, 1999; 100(4): 413 - 418.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Dörschner, I. Uhde, C. Schwanstecher, and M. Schwanstecher
Stoichiometry of Sulfonylurea-Induced ATP-Sensitive Potassium Channel Closure
Mol. Pharmacol., June 1, 1999; 55(6): 1060 - 1066.
[Abstract] [Full Text]


Home page
Plant CellHome page
N. Leonhardt, A. Vavasseur, and C. Forestier
ATP Binding Cassette Modulators Control Abscisic Acid–Regulated Slow Anion Channels in Guard Cells
PLANT CELL, June 1, 1999; 11(6): 1141 - 1152.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
K. N. Garratt, P. A. Brady, N. L. Hassinger, D. E. Grill, A. Terzic, and D. R. Holmes Jr.
Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction
J. Am. Coll. Cardiol., January 1, 1999; 33(1): 119 - 124.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y. Shimoni, P. E. Light, and R. J. French
Altered ATP sensitivity of ATP-dependent K+ channels in diabetic rat hearts
Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E568 - E576.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Gögelein, J. Hartung, H. C. Englert, and B. A. Schölkens
HMR 1883, a Novel Cardioselective Inhibitor of the ATP-Sensitive Potassium Channel. Part I: Effects on Cardiomyocytes, Coronary Flow and Pancreatic beta -Cells
J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1453 - 1464.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
P. A. Brady, A. E. Alekseev, and A. Terzic
Operative Condition–Dependent Response of Cardiac ATP-Sensitive K+ Channels Toward Sulfonylureas
Circ. Res., February 9, 1998; 82(2): 272 - 278.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Yokoshiki, M. Sunagawa, T. Seki, and N. Sperelakis
ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells
Am J Physiol Cell Physiol, January 1, 1998; 274(1): C25 - C37.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Leonhardt, E. Marin, A. Vavasseur, and C. Forestier
Evidence for the existence of a sulfonylurea-receptor-like protein in plants: Modulation of stomatal movements and guard cell potassium channels by sulfonylureas and potassium channel openers
PNAS, December 9, 1997; 94(25): 14156 - 14161.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. L. Hofman, K. Hiatt, M. C. Yoder, and S. A. Rivkees
A1 adenosine receptors potently regulate heart rate in mammalian embryos
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1374 - R1380.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Higuchi, K. Miyagi, S. Kayo, and M. Sakanashi
Acceleration of stiffness in underperfused diabetic rat hearts by glyburide, a KATP channel blocker, and its prevention by levcromakalim and insulin
Cardiovasc Res, August 1, 1997; 35(2): 303 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Isomoto, C. Kondo, M. Yamada, S. Matsumoto, Y. Horio, Y. Matsuzawa, and Y. Kurachi
A Novel Sulfonylurea Receptor Forms with BIR (Kir6.2) a Smooth Muscle Type ATP-sensitive K+ Channel
J. Biol. Chem., October 4, 1996; 271(40): 24321 - 24324.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. R. Lopez, R. Jahangir, A. Jahangir, W. K. Shen, and A. Terzic
POTASSIUM CHANNEL OPENERS PREVENT POTASSIUM-INDUCED CALCIUM LOADING OF CARDIAC CELLS: POSSIBLE IMPLICATIONS IN CARDIOPLEGIA
J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 820 - 831.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. Tominaga, M. Horie, S. Sasayama, and Y. Okada
Glibenclamide, an ATP-Sensitive K+ Channel Blocker, Inhibits Cardiac cAMP-Activated Cl- Conductance
Circ. Res., August 1, 1995; 77(2): 417 - 423.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.